| 我院3种口服降糖药治疗2型糖尿病的成本-效果分析 |
| |
| 引用本文： | 吴瀛达,蒋剑梅. 我院3种口服降糖药治疗2型糖尿病的成本-效果分析[J]. 海峡药学, 2006, 18(5): 170-172 |
| |
| 作者姓名： | 吴瀛达 蒋剑梅 |
| |
| 作者单位： | 浙江温州医学院附属二院药剂科,温州,325027 |
| |
| 摘 要： | 目的评价我院3种口服降糖药治疗2型糖尿病的临床效果,并探讨其经济学效果。方法选择102例2型糖尿病患者随机分成3组,A组:格列美脲口服:B组:吡格列酮口服;C组:二甲双胍口服,2个月后比较临床效果并进行成本效果分析。结果3种方案的总成本分别为570.40元、596.30元、498.10元;成本效果比分别为6.42、7.07、5.21。结论C组方案为最佳方案。
|
| 关 键 词： | 成本-效果分析 2型糖尿病 格列美脲 吡格列酮 二甲双胍 |
| 文章编号： | 1006-3765（2006）05-0170-03 |
Cost－effectiveness Analysis of Three Kinds of Oral Hypoglycemic Drugs for Treating Type－2 DM in our Hospital |
| |
| WU Ying-da,JIANG Jian-mei. Cost－effectiveness Analysis of Three Kinds of Oral Hypoglycemic Drugs for Treating Type－2 DM in our Hospital[J]. Strait Pharmaceutical Journal, 2006, 18(5): 170-172 |
| |
| Authors: | WU Ying-da JIANG Jian-mei |
| |
| Affiliation: | Dept. of Pharmacy, The Second Affiliated Hospital of Wenzhou Medical College, Wenzhou 325027 China |
| |
| Abstract: | OBJECTIVE To evaluate the clinical and economic effects of three hypoglycemic drugs for type-2 DM.METHODS 102cases of type-2 DM patients were divided randomly into 4 groups,group A:glimepiride po;group B:pioglitazone po;group C:metformin po.The clinical effects were compared and the cost-effectiveness analysis was used after 2 months.RESULTS The costs of three schemes were 570.40 yuans,596.40 yuans and 398.10 yuans,the cost-effectiveness ratios were 6.42,7.07 and 5.21.CONCLUSION Group C is the best scheme. |
| |
| Keywords: | Cost-effectiveness analysis Type-DM Glimepiride Piolitazone Metrormin |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
